Aurobindo Pharma Share Price Today - Live Aurobindo Pharma Stock Price NSE/BSE

COMPANY SNAPSHOT

Aurobindo Pharma Share Price

BUY SELL

BSE Code: 524804
|
NSE Symbol: AUROPHARMA
|
ISIN: INE406A01037

1160.00

12.20 (1.06%)

Open (Rs)

1160.00
Close (Rs)

1147.80
High (Rs)

1176.20
Low (Rs)

1147.00

Face Value

1
Market Capital (Cr.)

67373.03
Daily Volume

1501372
Life Time High

1592.00
Life Time Low

80.15
52 Week High

1592.00
52 Week Low

1010.00

Price Performance ADVANCED CHARTING >

Charting Corner

COMPARE

Key Ratios

	STOCK	IND.AVG.
Price/Earning TTM	19.5382	30.0100
Price/Book	3.2400	4.3400
Price/Sales TTM	8.0700	8.8800
Rev Growth (3 yrs Avg.)	25.8800	30.0000
EPS Growth (3 yrs Avg.)	52.9700	-41.5200
ROE TTM	10.0600	4.9700
Debt/Equity	0.1400	0.3200
ROC TTM	11.5600	9.7300
Dividend Yield	0.4100	0.3000
PBIDTM %	26.39	-44.55
PBTM %	21.57	-79.17
PATM %	15.98	-64.43

Market Analysis

3Yr's Sales V/S Peers

3Yr's PAT V/S Peers

3Yr's Dividend V/S Peers

Promoters holdings

Corporate Action 3Yrs

Event Calender

Compare This Stock With

COMPARING WITH

ADVANCE CHARTING FOR MORE COMPARISION

Top News

Aurobindo Pharmas arm incorporates wholly owned subsidiary in Netherlands

28-MAY | 18:02

The object of incorporation of this WOS is to expand the biopharma products business in Europe

Aurobindo Pharmas arm obtains marketing authorisation from MHRA for biosimilar Zefylti

14-MAY | 09:24

Earlier in February 2025, Zefylti has received the marketing authorisation in the European Union from the European Commission

Aurobindo Pharmas arm gets USFDA&apos;s nod to manufacture, market Dasatinib tablets

23-APR | 14:41

The product is expected to be launched in Q1FY26

Aurobindo Pharma gets USFDAs nod to manufacture, market Rivaroxaban Tablets USP

14-APR | 09:44

The product will be launched in Q1FY26

USFDA concludes inspection at Raleigh plant of Aurobindo Pharmas arm

12-APR | 12:18

At the conclusion, the USFDA issued a Form 483 with 11 observations

Aurobindo Pharmas arm gets marketing authorization for Dyrupeg

07-APR | 11:30

Earlier in January 2025, the Committee for Medicinal Products of European Medicines Agency had adopted positive opinion recommending the approval of Dyrupeg

Peers Companies

Stock	LTP(CHG%)	Intraday
Ranbaxy ..	859.80 (5.63)
Natco P ..	879.55 (2.00)
Concord ..	1655.30 (1.20)
Lupin	1960.00 (0.95)
Sai Lif ..	735.90 (0.90)

FAQ

What is the share price of Aurobindo Pharma?

▶

The current share price of Aurobindo Pharma is 1160.00

What is the face value of Aurobindo Pharma?

▶

The face value of Aurobindo Pharma is 1.

What is the market cap of Aurobindo Pharma?

▶

Aurobindo Pharma has a market cap of 67373.03.

What is the lifetime high of Aurobindo Pharma

▶

The lifetime high of Aurobindo Pharma is 1592.00.

What is the lifetime low of Aurobindo Pharma?

▶

The lifetime low of Aurobindo Pharma is 80.15.

What is the 52-week low of Aurobindo Pharma?

▶

The 52-week low of Aurobindo Pharma is 1010.00.

What is the 52-week high of Aurobindo Pharma?

▶

The 52-week high of Aurobindo Pharma is 1592.00.